Results 221 to 230 of about 303,574 (253)

In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor

Kidney International, 1999
Ellis D Avner, E D Avner, W E Sweeney
exaly  

Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients

Thyroid, 2018
Ole-Petter Hamnvik, Chirag Vyas, Melissa G Lechner   +2 more
exaly  

Vatalanib: the clinical development of a tyrosine kinase inhibitor of angiogenesis in solid tumours

Expert Opinion on Investigational Drugs, 2007
Anne Thomas, Dirk Laurent
exaly  

Hypothyroidism During Tyrosine Kinase Inhibitor Therapy Is Associated with Longer Survival in Patients with Advanced Nonthyroidal Cancers

Thyroid, 2018
Ole-Petter Hamnvik, Chirag Vyas, Melissa G Lechner   +2 more
exaly  

Tyrosine kinase inhibitors

2001
FRALEY MARK E, HAMBAUGH SCOTT R, HUNGATE RANDALL W   +2 more
openaire   +9 more sources

Unraveling the complexity of tyrosine kinase inhibitor–resistant populations by ultra-deep sequencing of the BCR-ABL kinase domain

Blood, 2013
Francesca Palandri, Cristina Papayannidis, Maria TERESA Bochicchio   +2 more
exaly  

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Blood, 2013
Anders Själander, Per Ljungman, Martin Höglund   +2 more
exaly  

TYROSINE KINASE INHIBITORS

2008
KIM ANNETTE S, ZHANG XUFANG
openaire   +2 more sources

Inhibitors of Bruton's tyrosine kinase

2010
BERTHEL STEVEN, FIROOZNIA FARIBORZ, FISHLOCK DANIEL, HONG JUN-BAE, LOU YAN, LUCAS MATTHEW, OWENS TIMOTHY D, SARMA KESHAB, SWEENEY ZACHARY KEVIN, TAYGERLY JOSHUA PAUL GERGELY   +9 more
  +12 more sources

TYROSINE KINASE INHIBITORS

2012
GOLDSTEIN DAVID MICHAEL, BRAMELD KENNETH ALBERT   +1 more
openaire   +3 more sources